COSCIENS Biopharma Inc. Postemployment Benefit Expense Defined Benefit Plans
COSCIENS Biopharma Inc. (CSCIF) reported Postemployment Benefit Expense Defined Benefit Plans of $85.00 thousand for the 3-month period ending 2022-03-31, per its 6-K filed 2022-05-11.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans · last filed 2022-05-11
- COSCIENS Biopharma Inc. postemployment benefit expense defined benefit plans for the quarter ending 2022-03-31 was $85.00K, a 123.68% increase year-over-year.
- COSCIENS Biopharma Inc. postemployment benefit expense defined benefit plans for the quarter ending 2021-09-30 was $41.00K, a 16.33% decline year-over-year.
- COSCIENS Biopharma Inc. postemployment benefit expense defined benefit plans for the quarter ending 2021-06-30 was $35.00K.
- COSCIENS Biopharma Inc. postemployment benefit expense defined benefit plans for the quarter ending 2021-03-31 was $38.00K.
| Period end | Postemployment Benefit Expense Defined Benefit Plans 3 month | Postemployment Benefit Expense Defined Benefit Plans 6 month | Postemployment Benefit Expense Defined Benefit Plans 9 month | Postemployment Benefit Expense Defined Benefit Plans 12 month |
|---|---|---|---|---|
| 2022-03-31 | $85.00K 6-K · filed 2022-05-11 | |||
| 2021-09-30 | $41.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $76.00K derived: sum of 2 quarters · filed 2021-11-04 | $114.00K 6-K · filed 2021-11-04 | |
| 2021-06-30 | $35.00K derived: 6-K 6 month − 6-K 3 month · filed 2021-08-05 | $73.00K 6-K · filed 2021-08-05 | ||
| 2021-03-31 | $38.00K 6-K · filed 2022-05-11 | |||
| 2020-09-30 | $49.00K derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | $141.00K 6-K · filed 2021-11-04 | ||
| 2020-06-30 | $92.00K 6-K · filed 2021-08-05 | |||
| 2018-12-31 | $275.00K 20-F · filed 2019-04-01 | |||
| 2017-12-31 | $441.00K 20-F · filed 2019-04-01 | |||
| 2016-12-31 | $500.00K 20-F · filed 2019-04-01 | |||
| 2015-12-31 | $511.00K 20-F · filed 2018-03-28 |